← Back to Search

ESP Block for Pain After Kidney Stone Surgery

N/A

Recruiting

Led By Jason Buehler, MD

Research Sponsored by University of Tennessee Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM

Be older than 18 years old

Must not have

Emergent surgery status

History of Guillain-Barre' Syndrome

Timeline

Screening 3 weeks

Treatment Varies

Follow Up number of days in hospital (inpatient) from day of surgery (day 1) until discharge post-surgery in 24 hour increments up to 30 days

Awards & highlights

Approved for 60 Other Conditions

All Individual Drugs Already Approved

Summary

This trial is investigating whether or not a certain type of nerve block can help reduce pain and the amount of pain medication needed after a surgery to remove kidney stones.

Who is the study for?

This trial is for English-speaking adults over 18 who are having non-emergency kidney stone surgery (percutaneous nephrolithotomy) during weekdays. They must be able to understand and explain the consent process, and women of childbearing age need a negative pregnancy test.

What is being tested?

The study tests if an ESP block with Ropivacaine and Dexamethasone reduces painkiller needs after kidney stone surgery compared to a saline solution control. It also looks at its effect on reported pain levels post-surgery.

What are the potential side effects?

Possible side effects may include discomfort or pain at the injection site, allergic reactions to medications used in the ESP block, nerve damage, low blood pressure, or changes in heart rate.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult scheduled for a kidney stone removal surgery on a weekday between 6 AM and 4 PM.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I require immediate surgery.

Select...

I have had Guillain-Barre Syndrome in the past.

Select...

I have an infection at a specific site.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ number of days in hospital (inpatient) from day of surgery (day 1) until discharge post-surgery in 24 hour increments up to 30 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~number of days in hospital (inpatient) from day of surgery (day 1) until discharge post-surgery in 24 hour increments up to 30 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and number of days in hospital (inpatient) from day of surgery (day 1) until discharge post-surgery in 24 hour increments up to 30 days for reporting.